Projects | Investors | Warrants | Media | News | Events | Contact
Radio interview with Linda Sampson, CEO of MaraPharm Ventures Inc
About Linda Sampson
Linda Sampson brings a dynamic energy, a wealth of talent, and a multi-layered business expertise to the Company. She is a business start-up professional, with a history of ground-up to successful ventures. An accomplished sales professional, marketer, designer, developer, with international experience, she brings superior business branding skills and internal administrative talents to Marapharm.
Corporate Overview
Marapharm Ventures Inc. (CSE:MDM) (OTC:MRPHF) is a developmental stage publicly traded medical marijuana company with operations based in British Columbia.
Through its wholly owned operating subsidiary Marapharm Inc., the Company has applied to Health Canada to become a licensed producer under the Marijuana for Medical Purposes Regulations (MMPR) issued pursuant to the Controlled Drugs and Substances Act (Canada). Marapharm’s initial facility, a proposed 22,000 sq.ft state-of-the-art designed-to-suit cultivation facility, will be constructed on an 11 acre leased site in Kelowna, British Columbia.
The Company’s growth strategy will be to build facilities or acquire licenses in the United States, determined by identifying opportunities and researching the direction and location of sales. The company has currently focused its attention on opportunities in Nevada and Washington.
Land has been purchased in Apex Business Park in the City of North Las Vegas, Nevada, for purposes of building a cultivation and production facility that will house three medical marijuana licenses.
In Washington, the Company has an opportunity to lease a facility to an I-502, tier 3 license holder. The licensee holds a production license for 30,000sq’ and a processing license with unlimited potential.
Marapharm has also purchased and is developing an all-natural hemp oil product line called, Maragold, which will be ready for market within a few months.
Company Highlights
Innovative – Suite of innovative cannabis products and services that will provide the company with a first-leader advantage in under-serviced and emerging markets and growth sectors.
Strategic – Dual growth strategy in Canada and the U.S.
Sales – In Canada – will be proprietary internet, mobile and web-based processes to create virtual store-front opportunities for approved buyers. In the U.S.: Nevada – we have entered into LOI’s with 3 dispensaries for our entire production. Colorado – This facility has both a medical and recreational dispensary. California – entered into an LOI for a dispensary.
Production – Brand new, energy efficient facilities have been designed to provide maximum product yield at lower cost.
Management – Proven management group that possess extensive business, cultivation and quality assurance experience.
Security – Security personnel and state-of-the-art systems to govern access to production departments and to support the required record-keeping responsibilities expected by regulators.
Market Opportunity
The North American market for legalized medical and adult use marijuana has been projected to conservatively exceed $11.5 billion by 2018. The market for medicinal use in Canada was estimated at $144 million in 2014 and expected to grow by 23% per year to $1.3 billion over the next 10 years.
In the U.S. the legal cultivation of medical and adult use marijuana is a field set to bring prosperity due to changes at the regulatory level combined with the groundswell of acceptance for the idea of use itself. Currently there are 23 states that have legalized medical marijuana, 4 states have legalized adult use marijuana and many more states (including Nevada) have ballot measures in place for the November 2016 elections. In Canada the newly established MMPR has opened up the market to large scale production and pending the outcome of the 2015 election could be legalized.
Legal Disclaimer/Disclosure: This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this Report should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. We make no guarantee, representation or warranty and accept no responsibility or liability as to its accuracy or completeness. Expressions of opinion are subject to change without notice. We assume no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this Report and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this Report.
